We’re building a diverse pipeline of cell therapies designed to overcome today’s toughest challenges — from persistence to scalability — and unlock new treatment possibilities across cancer, immune-mediated, and rare diseases.
Mark Cobbold
SVP, IO Discovery & Cell Therapy Oncology, AstraZeneca
Apply Now
- SR Pharmaceutical Sales Specialist Respiratory Primary Care, Pasadena CA R-248625 Wilmington, Delaware
- BDS Manufacturing Support Specialist - 12 month FTC R-252253 Dublin, Ireland
- Operation Support Specialist (Secondment) R-252191 Athlone, Ireland
- Director, Country Operations Management R-239022 Boston, Massachusetts
- Associate Medical Director Clinical Development Hematology R-250610 Boston, Massachusetts
- Medical Ethics Manager – (Above brand) R-251882 London, United Kingdom
- Executive Medical Director, Gastroenterology, Early R&I Clinical Development R-227687 Boston, Massachusetts
- 【AstraZeneca】【R&D】Director Quality Assurance APAC, R&D Quality Assurance R-233435 Osaka, Japan
- Attaché Scientifique Hospitalier – Onco-Hématologie – Languedoc (H/F) R-234374 France
- Executive Medical Director, Rheumatology, Early R&I Clinical Development R-236992 Boston, Massachusetts
